Showing 561 - 580 results of 100,755 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (we decrease)) ))', query time: 1.71s Refine Results
  1. 561

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  2. 562

    S1 Data - by Jordan A. Gunning (18143970)

    Published 2024
    “…Specifically, total immune cells (CD45+) decrease at days 2 and 5 following IR, macrophages (F4/80+CD11b+) decrease at day 2 and 5 and increase at day 30, while neutrophils (Ly6G+CD11b+) significantly increase at day 30 following IR. …”
  3. 563

    SARS-CoV-2 genome sequencing metrics. by Ludy R. Carmola (20978107)

    Published 2025
    “…We investigated viral and host factors, including vaccination status, that were associated with SARS-CoV-2 disease severity in a setting with low vaccination rates. …”
  4. 564

    SARS-CoV-2 variants by vaccination status. by Ludy R. Carmola (20978107)

    Published 2025
    “…We investigated viral and host factors, including vaccination status, that were associated with SARS-CoV-2 disease severity in a setting with low vaccination rates. …”
  5. 565
  6. 566
  7. 567
  8. 568
  9. 569
  10. 570
  11. 571

    Top 5 templates of CNN1 isoform 2 by PHYRE2 tool. by Muhammad Bilal Azmi (14519913)

    Published 2023
    “…<div><p>Prematurity is the foremost cause of death in children under 5 years of age. Genetics contributes to 25–40% of all preterm births (PTB) yet we still need to identify specific targets for intervention based on genetic pathways. …”
  12. 572
  13. 573
  14. 574

    R346K Mutation in the <i>Mu</i> Variant of SARS-CoV‑2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study by Filip Fratev (1799740)

    Published 2022
    “…The <i>Mu</i> variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. …”
  15. 575

    R346K Mutation in the <i>Mu</i> Variant of SARS-CoV‑2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study by Filip Fratev (1799740)

    Published 2022
    “…The <i>Mu</i> variant of SARS-CoV-2 has been recently classified as a variant of interest (VOI) by the World Health Organization (WHO) but limited data are available at the moment. …”
  16. 576
  17. 577
  18. 578
  19. 579

    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

    Published 2019
    “…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”
  20. 580

    Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera by Angela Bozza (8908091)

    Published 2023
    “…After the discovery of a mutation in the Janus kinase 2 (<i>JAK</i>2<sup>V617F</sup>), JAK2 inhibitors have been tested as second-line therapies. …”